首页> Translational gastroenterology and hepatology> Hepatobiliary cancers and immunotherapy: where are we now and where are we heading?

Hepatobiliary cancers and immunotherapy: where are we now and where are we heading?

导出 LinkOut

翻译打印收藏纠错

第一作者： Adam,Zayac

第一单位： Division of Hematology/Oncology, The Warren Alpert Medical School of Brown University/Lifespan Cancer Institute, Rhode Island Hospital, Providence, RI, USA.

作者： Adam,Zayac ^[1] ; Khaldoun,Almhanna ^[1]

作者单位： Division of Hematology/Oncology, The Warren Alpert Medical School of Brown University/Lifespan Cancer Institute, Rhode Island Hospital, Providence, RI, USA. ^[1]

关键词 Immunotherapy cholangiocarcinoma (CCA)gallbladder neoplasms hepatocellular carcinoma (HCC)

DOI 10.21037/tgh.2019.09.07

PMID 32190776

发布时间 2023-11-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Translational gastroenterology and hepatology

2020年5卷

8页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Translational gastroenterology and hepatology

2020年5卷

8页

检索历史清除

Hepatobiliary cancers and immunotherapy: where are we now and where are we heading?

Translational gastroenterology and hepatology

相似文献

同项目论文

Translational gastroenterology and hepatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Hepatobiliary cancers and immunotherapy: where are we now and where are we heading?

Translational gastroenterology and hepatology

相似文献

同项目论文

Translational gastroenterology and hepatology

相关期刊

检索历史清除